Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin

MeSH terms

• Adenosine / administration & dosage
• Adenosine / analogs & derivatives*
• Adenosine / pharmacology
• Adult
• Antithrombins / administration & dosage
• Antithrombins / pharmacology*
• Aspirin / administration & dosage
• Aspirin / pharmacology
• Blood Coagulation / drug effects*
• Clopidogrel
• Cross-Over Studies
• Drug Synergism
• Female
• Healthy Volunteers
• Hirudins / administration & dosage
• Hirudins / pharmacology*
• Humans
• Male
• Peptide Fragments / administration & dosage
• Peptide Fragments / pharmacology*
• Platelet Aggregation / drug effects
• Platelet Aggregation Inhibitors / administration & dosage
• Platelet Aggregation Inhibitors / pharmacology*
• Purinergic P2Y Receptor Antagonists / administration & dosage
• Purinergic P2Y Receptor Antagonists / pharmacology*
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / pharmacology
• Thrombelastography
• Ticagrelor
• Ticlopidine / administration & dosage
• Ticlopidine / analogs & derivatives*
• Ticlopidine / pharmacology